CLINICAL RESEARCH
Association of the triglyceride glucose index with
computed tomography-based low muscle mass
More details
Hide details
1
Department of Radiology, Shanghai Jiading District Central Hospital, Shanghai, China
2
Department of Radiology, Shanghai Longhua Hospital, Shanghai, China
3
Department of Radiology, Affiliated Hospital of Nanjing University, Nanjing, China
These authors had equal contribution to this work
Submission date: 2024-11-26
Final revision date: 2025-03-11
Acceptance date: 2025-04-06
Online publication date: 2025-05-05
Corresponding author
Xiao Chen
Department of Radiology
Affiliated Hospital of
Nanjing University
Chinese Medicine
Nanjing, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Recent studies have increasingly highlighted the connections between sarcopenia and insulin resistance. The triglyceride glucose (TYG) index has emerged as a promising surrogate marker for insulin resistance; however, its relationship with sarcopenia remains underexplored, and existing findings are inconsistent. This investigation examined this relationship in a Chinese cohort.
Material and methods:
The study group comprised individuals aged 50 years or older who underwent computed tomography scans for lung cancer screening. The cross-sectional area of erector spinae was utilized as a marker of muscle mass, with a threshold of 22 cm² indicating low muscle mass. Participants were categorized into four subgroups based on quartiles of the TYG index. Logistic regression models were employed to determine the relationship between TYG and low muscle mass.
Results:
Among the study cohort, 504 cases of low muscle mass were identified. The prevalence of low muscle mass showed a downward trend as the TYG increased (p = 0.023). The TYG index exhibited a positive correlation with muscle area ( = 0.98, 95% confidence interval (CI): 0.43–1.54). Higher TYG index values were linked to a reduced probability of low muscle area (odds ratio (OR) = 0.74, 95% CI: 0.59–0.95). The OR for low muscle area in the highest quartile compared to the lowest quartile was 0.61 (95% CI: 0.42–0.91). The restricted cubic spline curve corroborated these findings, indicating a consistent trend.
Conclusions:
Our findings demonstrated an inverse relationship between the TYG index and the probability of low muscle mass among older adults in the Chinese population.
REFERENCES (29)
1.
Bauer J, Morley JE, Schols A, et al. Sarcopenia: a time for action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle 2019; 10: 956-61.
2.
Cooper R, Kuh D, Cooper C, et al. Objective measures of physical capability and subsequent health: a systematic review. Age Aging 2011; 40: 14-23.
3.
Liccini A, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 2016; 17: 846-51.
4.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Aging 2019; 48: 16-31.
5.
Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from The Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011; 96: 2898-903.
6.
Park JH, Lee M, Shin H, et al. Lower skeletal muscle mass is associated with diabetes and insulin resistance: a cross-sectional study. Diabetes Metab Res Rev 2023; 39: e3681.
7.
Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol 2014; 43: 61-8.
8.
Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol 2024; 23: 8.
9.
Tao S, Yu L, Li J, et al. Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension. Cardiovasc Diabetol 2023; 22: 305.
10.
Son DH, Lee HS, Lee YJ, et al. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis 2022; 32: 596-604.
11.
Ahn S, Lee J, Lee J. Inverse association between triglyceride glucose index and muscle mass in Korean adults: 2008-2011 KNHANES. Lipids Health Dis 2020; 19: 243.
12.
Kim JA, Hwang SY, Yu JH, et al. Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008-2011. Sci Rep 2021; 11: 450.
13.
Chen Y, Liu C, Hu M. Association between triglyceride-glucose index and sarcopenia in China-a nationally representative cohort study. Exp Gerontol 2024; 190: 112419.
14.
Park JH, Lee MY, Shin HK, et al. Lower skeletal muscle mass is associated with diabetes and insulin resistance: a cross-sectional study. Diabetes Metab Res Rev 2023; 39: e3681.
15.
Wang R, Wang Y, Wei Z, et al. The association between HDL-c levels and computed tomography-based osteosarcopenia in older adults. BMC Musculoskelet Disord 2024; 25: 932.
16.
Wei Z, Gao X, Wang J, et al. Triglyceride glucose index is associated with vertebral fracture in older adults: a longitudinal study. Endocrine 2025; 87: 1022-30.
17.
Albano D, Messina C, Vitale J, et al. Imaging of sarcopenia: old evidence and new insights. Eur Radiol 2020; 30: 2199-208.
18.
Liu ZJ, Zhu CF. Causal relationship between insulin resistance and sarcopenia. Diabetol Metab Syndr 2023; 15: 46.
19.
Chen R, Zhang L, Zhang M, et al. The triglyceride-glucose index as a novel marker associated with sarcopenia in non-diabetic patients on maintenance hemodialysis. Ren Fail 2022; 44: 1615-21.
20.
Yang J, Liu C, Zhao S, et al. The association between the triglycerideglucose index and sarcopenia: data from the NHANES 2011–2018. Lipids Health Dis 2024; 23: 219.
21.
Kim B, Kim G, Lee Y, et al. Triglyceride–glucose index as a potential indicator of sarcopenic obesity in older people. Nutrients 2023; 15: 555.
22.
Li M, Liu Y, Gao L, et al. Higher triglyceride-glucose index and triglyceride glucose-body mass index protect against sarcopenia in Chinese middle-aged and older non-diabetic women: a cross-sectional study. Front Public Health 2025; 12: 1475330.
23.
Rahman MS, Hossain KS, Das S, et al. Role of insulin in health and disease: an update. Int J Mol Sci 2021; 22: 6403.
24.
Hua N, Qin C, Wu F, et al. High-density lipoprotein cholesterol level and risk of muscle strength decline and sarcopenia in older adults. Clin Nutr 2024; 43: 2289-95.
25.
Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012; 15: 12-22.
26.
Bielecka-Dabrowa A, Banach M, Wittczak A, et al. The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper. Arch Med Sci 2023; 19: 841-64.
27.
Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-50.
28.
Zhang H, Qi G, Wang K, et al. Oxidative stress: roles in skeletal muscle atrophy. Biochem Pharmacol 2023; 214: 115664.
29.
Biobaku F, Ghanim H, Batra M, et al. Macronutrient-mediated inflammation and oxidative stress: relevance to insulin resistance, obesity, and atherogenesis. J Clin Endocrinol Metab 2019; 104: 6118-28.